Twelve weeks of MICT significantly reduced the levels of inflammatory factors such as interleukin 6 and tumor necrosis factor-α, increase antioxidant capacity and promoted fat metabolism in individuals with obesity. This evidence concerns the gene IL6 and obesity disorder.